Citation: | YUAN Qin, YAO Fei, ZHANG Lu-rong, LIU Min. Regulation Mechanism of Yupingfeng San on Angiogenesis in Liver Cancer Microenvironment[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(2): 205-210. |
[1] |
BAI L,YANG JC,OK JH, et al.Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration[J]. Int J Cancer, 2011, 130(1): 253-262.
|
[2] |
LI C, LIU T, BAZHIN AV, et al. The sabotaging role of myeloid cells in anti-angiogenic therapy: Coordination of angiogenesis and immune suppression by hypoxia[J]. J Cell Physiol, 2017, 232: 2312-2322.
|
[3] |
SHERMAN M. Hepatocellular carcinoma: Epidemiology, surveillance, and diagnosis[J]. Semin Liver Dis, 2010, 30(1): 3-16.
|
[4] |
PRENDERGAST GC, JAFFEE EM. Cancer immunologists and cancer biologists: Why we didn't talk then but need to now[J]. Cancer Res, 2007, 67(8): 3500-3504.
|
[5] |
张露蓉,姚霏,江国荣. 玉屏风散对Hepa1-6 肝癌荷瘤小鼠免疫调节的影响[J]. 东南大学学报,2014,33(1):34.
|
[6] |
张露蓉, 姚霏, 江国荣, 等. 玉屏风散直接抑制和免疫调节抗肝细胞癌作用的实验研究[J]. 中华中医药学刊, 2014, 32(5):1046- 1050.
|
[7] |
ZHANG HJ, TANG XY, JU BL, et al. Effect of Yu Ping Feng San on the growth of tumor and immunological function in tumor bearing nude mice[J]. Chin J Cell Mol Immunol, 2008, 24: 683-685.
|
[8] |
FEURINO LW, ZHANG Y, BHARADWAJ U, et al. IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells[J]. Cancer Biol Ther, 2007, 6(7):1096- 1100.
|
[9] |
ZHANG H, YANG R. Resveratrol inhibits VEGF gene expression and proliferation of hepatocarcinoma cells[J]. Hepatogastroenterology, 2014; 61(130):410-412.
|
[10] |
YING SO, CONNOR B, RATOFF J, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity[J]. J Immunol, 2005, 174: 8183-8190.
|
[11] |
OLKHANUD PB, ROCHMAN Y, BODOGAI M, et al. Thymic stromal lymphopoietin is a key mediator of breast cancer progression[J]. Immunol, 2011, 186: 5656-5662.
|
[12] |
DOURLAT J, LIU WQ, SANCIER F, et al. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity[J]. Biochimie, 2009, 91(8):996- 1002.
|
[13] |
XIE TX, WEI D, LIU M, et al. STAT3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis[J]. Oncogene, 2004, 23(20): 3550-3560.
|
[14] |
CHEN Z, HAN ZC. STAT3: A critical transcription activator in angiogenesis[J]. Med Res Rev, 2008, 28: 185-200.
|
[15] |
SURRAMANIAM A, SHANMUGAM MK, PERUMAL E, et al. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma[J]. Biochim Biophys Acta-Rev Cancer, 2013, 1835: 46-60.
|